ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,526, issued on Dec. 30, was assigned to ALLIGATOR BIOSCIENCE AB (Lund, Sweden).
"Anti-CD137 antibodies and uses thereof" was invented by Peter Ellmark (Lund, Sweden), Sara Fritzell (Lund, Sweden), Christina Furebring (Lund, Sweden), Jessica Petersson (Lund, Sweden), Anna Sall (Lund, Sweden), Karin Enell Smith (Lund, Sweden), Laura Varas (Lund, Sweden), Laura Von Schantz (Lund, Sweden) and Niina Veitonmaki (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies (and fragments, variants, fusions and derivatives thereof) with binding specificity for domain 2 of human CD137 which are capable of inhibiting...